Takeda Pharmaceutical Co., Ltd. (TAK)
18.29
+0.05
(+0.27%)
USD |
NYSE |
Aug 25, 12:57
Takeda Pharmaceutical Total Assets (Quarterly) : 96.37B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 96.37B |
| March 31, 2026 | 97.50B |
| December 31, 2025 | 98.30B |
| September 30, 2025 | 97.98B |
| June 30, 2025 | 96.95B |
| March 31, 2025 | 95.28B |
| December 31, 2024 | 96.12B |
| September 30, 2024 | 101.88B |
| June 30, 2024 | 100.88B |
| March 31, 2024 | 99.83B |
| December 31, 2023 | 100.89B |
| September 30, 2023 | 99.66B |
| June 30, 2023 | 102.35B |
| March 31, 2023 | 104.87B |
| December 31, 2022 | 102.35B |
| September 30, 2022 | 100.79B |
| June 30, 2022 | 103.53B |
| March 31, 2022 | 108.57B |
| December 31, 2021 | 110.27B |
| September 30, 2021 | 112.57B |
| June 30, 2021 | 114.04B |
| March 31, 2021 | 116.85B |
| December 31, 2020 | 119.00B |
| September 30, 2020 | 117.64B |
| June 30, 2020 | 116.92B |
| Date | Value |
|---|---|
| March 31, 2020 | 118.76B |
| December 31, 2019 | 119.91B |
| September 30, 2019 | 119.18B |
| June 30, 2019 | 125.77B |
| March 31, 2019 | 124.61B |
| December 31, 2018 | 52.57B |
| September 30, 2018 | 37.64B |
| June 30, 2018 | 37.55B |
| March 31, 2018 | 38.61B |
| December 31, 2017 | 39.15B |
| September 30, 2017 | 38.87B |
| June 30, 2017 | 38.68B |
| March 31, 2017 | 39.09B |
| December 31, 2016 | 35.51B |
| September 30, 2016 | 37.54B |
| June 30, 2016 | 37.21B |
| March 31, 2016 | 34.02B |
| December 31, 2015 | 34.83B |
| September 30, 2015 | 35.18B |
| June 30, 2015 | 35.31B |
| March 31, 2015 | 35.82B |
| December 31, 2014 | 38.81B |
| September 30, 2014 | 41.68B |
| June 30, 2014 | 43.80B |
| March 31, 2014 | 42.48B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 25.32B |
| Ono Pharmaceutical Co., Ltd. | 6.672B |
| Astellas Pharma, Inc. | 22.72B |
| Sanofi | -- |
| Eisai Co., Ltd. | 9.587B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 49.87B |
| Shareholders Equity (Quarterly) | 46.50B |
| Debt to Equity Ratio | 0.6536 |
| Current Ratio | 1.140 |
| Net Debt Paydown Yield | 1.43% |